Sclerostin, an emerging therapeutic target for treating osteoporosis and osteoporotic fracture: A general review-Reference-Cited by-同舟云学术

Sclerostin, an emerging therapeutic target for treating osteoporosis and osteoporotic fracture: A general review

Published:2016-01 Issue: Volume:4 Page:1-13
ISSN:2214-031X
Container-title:Journal of Orthopaedic Translation
language:en
Short-container-title:Journal of Orthopaedic Translation

Author:

Suen Pui Kit,Qin Ling

Publisher

Elsevier BV

Subject

Orthopedics and Sports Medicine

Reference140 articles.

1. Incidence and economic burden of osteoporosis-related fractures in the United States, 2005–2025;Burge;J Bone Miner Res,2007

2. Epidemiology of osteoporotic fractures;Johnell;Osteoporos Int,2005

3. A reference standard for the description of osteoporosis;Kanis;Bone,2008

4. Report of a WHO study group;Assessment of fracture risk and its application to screening for postmenopausal osteoporosis;World Health Organ Tech Rep Ser,1994

5. Trends in hip fracture incidence and mortality in Chinese population from Hong Kong 2001–09;Chau;Age Ageing,2013

Cited by 70 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sclerostin inhibition in rare bone diseases: Molecular understanding and therapeutic perspectives;Journal of Orthopaedic Translation;2024-07

2. Discovery of the small molecular inhibitors against sclerostin loop3 as potential anti-osteoporosis agents by structural based virtual screening and molecular design;European Journal of Medicinal Chemistry;2024-05

3. A bone adhesive enhances osteoporotic fracture repair by regulating bone homeostasis;NPG Asia Materials;2024-04-12

4. Unique Spatial Transcriptomic Profiling of the Murine Femoral Fracture Callus: A Preliminary Report;Cells;2024-03-16

5. Osteocyte-mediated mechanical response controls osteoblast differentiation and function;Frontiers in Physiology;2024-03-11